Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants

When developing national guidelines for antiretroviral therapy. The 2010 guidelines are developed to provide international standards, primarily for low- and middle-income settings, in support of the global scale-up of more effective interventions aimed at preventing MTCT in resource-limited settings.

Selection

  • Sub-categories HIV/AIDS
  • Commodities Medicines
  • Latest update 2010
  • Version 2010 version
  • Developed by WHO/OMS
  • When to use When developing national guidelines for antiretroviral therapy. The 2010 guidelines are developed to provide international standards, primarily for low- and middle-income settings, in support of the global scale-up of more effective interventions aimed at preventing MTCT in resource-limited settings.
  • Languages English
  • Level of use Central
  • Form PDF document file, Information source document (treatment guidelines), 4.4 MB
  • Amount of training / TA required None
  • Inputs & outputs Inputs: none. Outputs: Standardized ART formulary for pregnant women with simplified patient management and standardized laboratory monitoring.
  • Cost Free
  • Advantages Important reference for development of national treatment guidelines
  • Limitations None
  • Availability http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf
  • Remarks Contact: Tin Tin Sint (WHO/HIV)
  • Contact sintt@who.int
  • Submission date 2010-11-29 19:56:16